Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Addition to Ropivacaine in ESPB for CABG
NCT06981949Phase 4Not yet recruiting
- Sponsor
- Lebanese American University
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Lebanese American University. Primary endpoint: Duration of effective pain relief. Planned start May 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06981949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06981949.